Health
Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward – TCTMD
DREAM-HF provides hints of an anti-inflammatory effect and benefits beyond the heart, setting up future trials.
Targeted injection of mesenchymal precursor cells (MPCs) into the myocardium is safe but does not reduce recurrent nonfatal decompensated heart failure (HF) events in patients with chronic HF with reduced ejection fraction (HFrEF), the randomized DREAM-HF…
Continue Reading
-
Noosa News21 hours agoDangerous storm pounds south-east Queensland with giant hail, blackouts and widespread damage
-
Noosa News23 hours agoPassenger footage of Sea World helicopters colliding
-
Noosa News19 hours agoLawnton house fire: Savannah Kerr, 13, dies in blaze as four others remain critically injured
-
Noosa News21 hours agoDarkness rolls over Brisbane in brief-but-mighty storm